ESR1 and breast cancer: Triple-negative breast cancer (TNBC) accounts for approximately 10%–15% of all breast cancers and is defined as breast cancer that is negative for the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2)1.